TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive New NCI division For Center, Training, Organ Systems, Construction Seen As Likely Prospect April 17, 1987